14. Novo Nordisk A/S Slide no 14 19 July 2022
UKPDS-Stratton IM et al. BMJ 2000;321:405-412.
Correlation between a 1% HbA1C decrease and reduced risk of complications (T2DM)
43% 37% 19% 14%
Lower extremity
amputation or fatal
peripheral vascular
disease
Microvascular
disease
Cataract extraction
Myocardial
infarction
16%
Heart failure
12%
Stroke
Cardiovascular complications
1% drop in HbA1C
00:05:50